General
New $160,000 drug for multiple myeloma blood cancer to be added to PBS at a cost to patients of $480
More than 1,000 patients with an incurable type of blood cancer are expected to benefit from a “completely new” treatment that will be subsidised by the Federal Government in the new year.
Key points:
- Multiple myeloma is a type of blood cancer that causes about 1,000 deaths in Australia each year
- The drug Darzalex works by binding to the cancerous cells and allowing them to be destroyed
- Myeloma Australia’s chief executive says the drug getting listed on the PBS is “heart-lifting” news
Darzalex, which will be listed on the Pharmaceutical Benefits Scheme (PBS) from January 1, is a medicine used to treat multiple myeloma, a cancer that causes cancerous plasma cells to accumulate in bone marrow and crowd out healthy blood cells.
An estimated…
Continue Reading
-
Noosa News15 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General23 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
Business19 hours agoWhy are ASX 200 tech stocks like Xero shares taking a beating on Monday?
-
Noosa News20 hours agoEight New Year’s Eve Events in Brisbane 2026